Skip to Main Content

Paper Details

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
J Clin Invest
5
2020
NEK2, glioblastoma, histone methyltransferase EZH2

Datasets